A committee of Israel's Knesset has approved legislation that would amend the country's patent law to allow generic drugmakers to take manufacturing steps before the patent on the original drug has expired. To counter the impact of the change, the law also would authorize the Israel Patent Office to grant five-year extensions of the patents for original drugs.

Full Story:
Globes (Israel)

Related Summaries